Notice of Intent to issue a Sole Source Award for Research and Development of 10,000 lateral flow devices for pre-clinical and clinical studies to rapidly detect HIV

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Beacon Scientific INC for the manufacture of 10,000 lateral flow devices. These devices will be used in pre-clinical and clinical studies to evaluate their performance and utility in rapidly detecting HIV antiretroviral usage in point-of-care facilities. The contract action is for commercial services, and the government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. • The devices will be used for pre-clinical and clinical studies. • The studies will evaluate the performance and utility of the devices in detecting HIV antiretroviral usage. • The contract is for commercial services. • The government intends to solicit and negotiate with only one source.